Skip to main content

Velcura Therapeutics, Scripps-PARC Institute for Advanced Biomedical Sciences


Velcura Therapeutics has developed a custom Affymetrix GeneChip array for monitoring changes in gene expression during human bone formation. The array will be used for researching osteoporosis and other bone diseases. The custom chip is available solely to Velcura for use within its own research labs and to Velcura’s strategic partners.

The Scripps-PARC Institute for Advanced Biomedical Sciences, a joint venture of the Scripps Research Institute and the Palo Alto Research Center, has developed a nanocalorimeter that it believes will enable researchers to design new drugs more quickly. The enthalpy array technology uses 250 nanoliter droplets of a test compound on 96-detector arrays and allows researchers to characterize larger numbers of samples in a shorter amount of time than traditional methods, the partners said.

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.